DrugPatentWatch Database Preview
FML-S Drug Profile
When do Fml-s patents expire, and when can generic versions of Fml-s launch?
The generic ingredient in FML-S is fluorometholone; sulfacetamide sodium. There are five drug master file entries for this compound. Additional details are available on the fluorometholone; sulfacetamide sodium profile page.
Summary for FML-S
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 72 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | FML-S at DailyMed |
US Patents and Regulatory Information for FML-S
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | FML-S | fluorometholone; sulfacetamide sodium | SUSPENSION/DROPS;OPHTHALMIC | 019525-001 | Sep 29, 1989 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
